Results 161 to 170 of about 52,371 (280)

Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review). [PDF]

Int J Oncol
Lu C, Zhou T, Zhang W, Wei L, Chen Q, Shi Y, Wang C, Yu L.   +7 more
europepmc   +1 more source

Diffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive BCRs binding protein modifications. [PDF]

Arthritis Res Ther
Euler N, Gonzalez-Sanchez AC, Clark E, Mildner H, Galesic M, Kemp A, Jangard M, Hellbacher E, Landegren N, Diaz-Gallo LM, Klareskog L, Malmström V, Baecklund E, Grönwall C.   +13 more
europepmc   +1 more source

Role of PET/CT in diffuse large B-cell lymphoma (Review). [PDF]

Mol Clin Oncol
Jing H, Shao H, Zhou D, Bi L.
europepmc   +1 more source

Human biomarker navigator

iMeta, Volume 5, Issue 5, October 2026.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Foreseeing what is to happen in DLBCL [PDF]

Blood, 2020
openaire   +2 more sources

The Power of Hematopoietic Stem Cell Transplantation (HSCT): A Curative Approach for Diffuse Large B‐Cell Lymphoma (DLBCL) Incidentally Detected in a SCID Baby

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Lymphoma is a rare complication of X‐linked severe combined immunodeficiency (X‐SCID) caused by IL2RG deficiency. We report an infant with IL2RG‐SCID who developed diffuse large B‐cell lymphoma (DLBCL) during pretransplant evaluation. A male infant with T−B+ SCID was diagnosed at 1 month of age and referred for hematopoietic stem cell ...
Burcu Sarıgül Cimi, Sule Haskologlu, Candan Islamoglu, Gokcan Ozturk, Nazlı Deveci, Hasret Erkmen, Selin Sevinc, Can Akal, Seda Kaynak Sahap, Sonay Özdemir, Suat Fitoz, Isınsu Kuzu, Emel Unal, Nurdan Tacyıldız, Figen Dogu, Aydan Ikinciogullari   +15 more
wiley   +1 more source

Rare But Specific B‐Cell Receptor Reactivity Against Coxsackievirus A24 in Primary Central Nervous System Lymphomas

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Introduction Primary central nervous system lymphoma (PCNSL) remains a distinct and aggressive malignancy whose underlying antigenic triggers are largely unknown. While autoantigens such as neurabin‐I and SAMD14 have been implicated, the potential role of infectious agents in driving clonal B‐cell receptor selection within the central nervous ...
Igor Age Kos, Onur Cetin, Natalie Fadle, Evi Regitz, Klaus‐Dieter Preuss, Stefan Lohse, Sigrun Smola, Sylvia Hartmann, Falko Fend, Karin Klingel, Florian Scherer, Elisabeth Schorb, Moritz Bewarder, Philipp Staber, Lorenz Thurner   +14 more
wiley   +1 more source

Navigating T-Cell-Directed Therapies in Transformed Follicular Lymphoma. [PDF]

Cancers (Basel)
Zelikson V, Karmali R.
europepmc   +1 more source

Nirmatrelvir/Ritonavir and Subsequent PCR Negativity in Patients With B‐Cell Lymphoma and Prolonged SARS‐CoV‐2 PCR Positivity: A Case Series

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Prolonged SARS‐CoV‐2 PCR positivity is increasingly recognized in immunocompromised patients. We retrospectively analyzed four patients with B‐cell lymphoma and prior anti‐CD20 antibody therapy who exhibited prolonged PCR positivity after COVID‐19 diagnosis.
Yutaka Natori, Hideyoshi Noji, Akiko Shichishima‐Nakamura, Satoru Kikuchi, Shigehira Saji   +4 more
wiley   +1 more source

Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem). [PDF]

Pharmaceuticals (Basel)
Galusic D, Zivkovic N, Basic-Kinda S, Dreta B, Ivic M, Dujmovic D, Moric-Peric M, Holik H, Franjic N, Sincic-Petricevic J, Hude-Dragicevic I, Aurer I.   +11 more
europepmc   +1 more source